{"id":"NCT05071313","sponsor":"Janssen Vaccines & Prevention B.V.","briefTitle":"A Study of an Ad26.RSV.preF-based Vaccine and High-dose Seasonal Influenza Vaccine, With and Without Coadministration, in Adults Aged 65 Years and Older","officialTitle":"A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Immunogenicity and Safety of Ad26.RSV.preF-based Vaccine and High-dose Seasonal Influenza Vaccine, With and Without Coadministration, in Adults Aged 65 Years and Older","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-10-04","primaryCompletion":"2022-04-20","completion":"2022-10-11","firstPosted":"2021-10-08","resultsPosted":"2023-09-13","lastUpdate":"2025-05-25"},"enrollment":777,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Influenza, Human Prevention","Respiratory Syncytial Viruses Prevention"],"interventions":[{"type":"BIOLOGICAL","name":"Ad26.RSV.preF-based vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"Quadrivalent High-dose Influenza Vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]}],"arms":[{"label":"Group 1: Coadministration (CoAd) Group","type":"EXPERIMENTAL"},{"label":"Group 2: Control Group","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the immunogenicity and safety of Ad26.RSV.preF-based vaccine and quadrivalent high-dose seasonal influenza vaccine when administered either concomitantly or separately.","primaryOutcome":{"measure":"Geometric Mean Titers (GMTs) of Hemagglutination Inhibition (HI) Antibodies Against Each of the Four Influenza Vaccine Strains as Measured by HI Assay","timeFrame":"28 days after vaccination with Fluzone on Day 1 (Day 29)","effectByArm":[{"arm":"Group 1: Ad26/Protein preF RSV Vaccine With Fluzone HD QIV + Placebo (CoAd Group)","deltaMin":178,"sd":null},{"arm":"Group 2: Placebo With Fluzone HD QIV + Ad26/Protein preF RSV Vaccine (Control Group)","deltaMin":179,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"65 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":8},"locations":{"siteCount":19,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":385},"commonTop":["Chills","Hypertension"]}}